Tianjin Ringpu Bio-Technology Co.,Ltd.
300119.SZ - Insider Information
Get informed when a big investor buys or sells
+ FollowMarket Cap$7.56B
Close$
$28.97
68.2% upside
Current Fair Value
68.2% upsideUndervalued by 68.2% based on the discounted cash flow analysis.
Insider Trades
Loading insider trades…
Congress Trades
Loading congress trades…
Share Statistics
| Market cap | $7.56 Billion |
|---|---|
| Enterprise Value | $8.90 Billion |
| Annual dividend | $0.40 |
| Dividend yield | 2.46% |
| Earnings per Share | $0.88 |
| Beta | 0.25 |
| Outstanding Shares | 454,159,392 |
Return
| Return on Equity | 7.16% |
|---|---|
| Return on Assets | 4.32% |
| Return on Invested Capital | 7.58% |
Valuation & Multiples
| P/E Ratio | 21.87 |
|---|---|
| PEG | -209.41 |
| Price to Sales | 2.46 |
| Price to Book Ratio | 1.57 |
| Enterprise Value to Revenue | 2.52 |
| Enterprise Value to EBIT | 20.66 |
| Enterprise Value to Net Income | 26 |
| Total Debt to Enterprise | 0.21 |
| Debt to Equity | 0.4 |
Revenue Sources
No data
Last Earnings Call
Report Date
October 29, 2026
EPS Estimate
-
Consensus analyst estimateRevenue Estimate
$943.04 M
Consensus analyst estimateNext Earnings Call
Expected Date
March 29, 2027
EPS Estimate
-
Consensus analyst estimateRevenue Estimate
-
Consensus analyst estimateInstitutional Sentiment (Put/Call)
No data available for the latest quarter.
Institutional Ownership
No data available for the latest quarter.
About Tianjin Ringpu Bio-Technology Co.,Ltd.
2,803 employees
CEO: Lei Xu
Established in 1998 and based in Tianjin, China, Tianjin Ringpu Bio-Technology Co.,Ltd. focuses on the research, development, manufacturing, and commercialization of a broad spectrum of animal health solutions. Their product portfolio in...